APO Research
Talk to an analyst

APO RESEARCH · REPORT

Combined Hormonal Contraceptives

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Combined Hormonal Contraceptives Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchCombined Hormonal Contraceptives Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Combined Hormonal Contraceptives Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Combined Hormonal Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Combined Hormonal Contraceptives Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Combined Hormonal Contraceptives Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Combined Hormonal Contraceptives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Combined Hormonal Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Combined Hormonal Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Combined Hormonal Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Combined Hormonal Contraceptives include Teva Pharmaceutical Industries, Johnson & Johnson, Mylan, Bayer, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals, ANI Pharmaceuticals, Allergan and Agile Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Combined Hormonal Contraceptives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Combined Hormonal Contraceptives market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Combined Hormonal Contraceptives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Combined Hormonal Contraceptives.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Combined Hormonal Contraceptives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Combined Hormonal Contraceptives Market by Company

Teva Pharmaceutical Industries

Johnson & Johnson

Mylan

Bayer

Ortho-McNeil-Janssen Pharmaceuticals

Noven Pharmaceuticals

ANI Pharmaceuticals

Allergan

Agile Therapeutics

Actavis

Combined Hormonal Contraceptives Segment by Type

Above 44 years

35-44 years

25-34 years

15-24 years

Combined Hormonal Contraceptives Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Combined Hormonal Contraceptives Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combined Hormonal Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Combined Hormonal Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combined Hormonal Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Combined Hormonal Contraceptives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Combined Hormonal Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Above 44 years Table 2. Major Company of 35-44 years Table 3. Major Company of 25-34 years Table 4. Major Company of 15-24 years Table 5. Global Combined Hormonal Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 7. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Type (2021-2026) Table 8. Global Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 9. Global Combined Hormonal Contraceptives Sales Market Share in Value by Type (2021-2026) Table 10. Global Combined Hormonal Contraceptives Price by Type (2021-2026) & (US$/Unit) Table 11. Global Combined Hormonal Contraceptives Sales by Type (2027-2032) & (K Units) Table 12. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Type (2027-2032) Table 13. Global Combined Hormonal Contraceptives Sales by Type (2027-2032) & (US$ Million) Table 14. Global Combined Hormonal Contraceptives Sales Market Share in Value by Type (2027-2032) Table 15. Global Combined Hormonal Contraceptives Price by Type (2027-2032) & (US$/Unit) Table 16. North America Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 17. North America Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 19. Europe Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 23. Latin America Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Combined Hormonal Contraceptives Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Combined Hormonal Contraceptives Sales by Type (2021-2026) & (US$ Million) Table 26. Combined Hormonal Contraceptives Industry Trends Table 27. Combined Hormonal Contraceptives Industry Drivers Table 28. Combined Hormonal Contraceptives Industry Opportunities and Challenges Table 29. Combined Hormonal Contraceptives Industry Restraints Table 30. Global Combined Hormonal Contraceptives Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Combined Hormonal Contraceptives Revenue Market Share by Company (2021-2026) Table 32. Global Combined Hormonal Contraceptives Sales by Company (2021-2026) & (K Units) Table 33. Global Combined Hormonal Contraceptives Sales Share by Company (2021-2026) Table 34. Global Combined Hormonal Contraceptives Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Combined Hormonal Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Combined Hormonal Contraceptives Major Company Production Sites and Headquarters Table 37. Global Combined Hormonal Contraceptives Company, Product Type & Application Table 38. Global Combined Hormonal Contraceptives Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Combined Hormonal Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Combined Hormonal Contraceptives Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Combined Hormonal Contraceptives Sales by Region (2021-2026) & (K Units) Table 43. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Region (2021-2026) Table 44. Global Combined Hormonal Contraceptives Sales by Region (2021-2026) & (US$ Million) Table 45. Global Combined Hormonal Contraceptives Sales Market Share in Value by Region (2021-2026) Table 46. Global Combined Hormonal Contraceptives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Combined Hormonal Contraceptives Sales by Region (2027-2032) & (K Units) Table 48. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Region (2027-2032) Table 49. Global Combined Hormonal Contraceptives Sales by Region (2027-2032) & (US$ Million) Table 50. Global Combined Hormonal Contraceptives Sales Market Share in Value by Region (2027-2032) Table 51. Global Combined Hormonal Contraceptives Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Combined Hormonal Contraceptives Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 54. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Application (2021-2026) Table 55. Global Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 56. Global Combined Hormonal Contraceptives Sales Market Share in Value by Application (2021-2026) Table 57. Global Combined Hormonal Contraceptives Price by Application (2021-2026) & (US$/Unit) Table 58. Global Combined Hormonal Contraceptives Sales by Application (2027-2032) & (K Units) Table 59. Global Combined Hormonal Contraceptives Sales Market Share in Volume by Application (2027-2032) Table 60. Global Combined Hormonal Contraceptives Sales by Application (2027-2032) & (US$ Million) Table 61. Global Combined Hormonal Contraceptives Sales Market Share in Value by Application (2027-2032) Table 62. Global Combined Hormonal Contraceptives Price by Application (2027-2032) & (US$/Unit) Table 63. North America Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 64. North America Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 66. Europe Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 70. Latin America Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Combined Hormonal Contraceptives Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Combined Hormonal Contraceptives Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Combined Hormonal Contraceptives Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Combined Hormonal Contraceptives Product Portfolio Table 87. Mylan Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Bayer Combined Hormonal Contraceptives Product Portfolio Table 92. Bayer Recent Development Table 93. Ortho-McNeil-Janssen Pharmaceuticals Company Information Table 94. Ortho-McNeil-Janssen Pharmaceuticals Business Overview Table 95. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio Table 97. Ortho-McNeil-Janssen Pharmaceuticals Recent Development Table 98. Noven Pharmaceuticals Company Information Table 99. Noven Pharmaceuticals Business Overview Table 100. Noven Pharmaceuticals Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Noven Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio Table 102. Noven Pharmaceuticals Recent Development Table 103. ANI Pharmaceuticals Company Information Table 104. ANI Pharmaceuticals Business Overview Table 105. ANI Pharmaceuticals Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ANI Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio Table 107. ANI Pharmaceuticals Recent Development Table 108. Allergan Company Information Table 109. Allergan Business Overview Table 110. Allergan Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Allergan Combined Hormonal Contraceptives Product Portfolio Table 112. Allergan Recent Development Table 113. Agile Therapeutics Company Information Table 114. Agile Therapeutics Business Overview Table 115. Agile Therapeutics Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Agile Therapeutics Combined Hormonal Contraceptives Product Portfolio Table 117. Agile Therapeutics Recent Development Table 118. Actavis Company Information Table 119. Actavis Business Overview Table 120. Actavis Combined Hormonal Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Actavis Combined Hormonal Contraceptives Product Portfolio Table 122. Actavis Recent Development Table 123. North America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Combined Hormonal Contraceptives Sales by Country (2021-2026) & (K Units) Table 125. North America Combined Hormonal Contraceptives Sales Market Share by Country (2021-2026) Table 126. North America Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Combined Hormonal Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 128. North America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Combined Hormonal Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Combined Hormonal Contraceptives Market Share by Country (2021-2026) Table 131. North America Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Combined Hormonal Contraceptives Market Share Forecast by Country (2027-2032) Table 133. Europe Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Combined Hormonal Contraceptives Sales by Country (2021-2026) & (K Units) Table 135. Europe Combined Hormonal Contraceptives Sales Market Share by Country (2021-2026) Table 136. Europe Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Combined Hormonal Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Combined Hormonal Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Combined Hormonal Contraceptives Market Share by Country (2021-2026) Table 141. Europe Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Combined Hormonal Contraceptives Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Combined Hormonal Contraceptives Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Combined Hormonal Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Combined Hormonal Contraceptives Market Share by Country (2021-2026) Table 151. Asia-Pacific Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Combined Hormonal Contraceptives Market Share Forecast by Country (2027-2032) Table 153. Latin America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Combined Hormonal Contraceptives Sales by Country (2021-2026) & (K Units) Table 155. Latin America Combined Hormonal Contraceptives Sales Market Share by Country (2021-2026) Table 156. Latin America Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Combined Hormonal Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Combined Hormonal Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Combined Hormonal Contraceptives Market Share by Country (2021-2026) Table 161. Latin America Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Combined Hormonal Contraceptives Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Combined Hormonal Contraceptives Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Combined Hormonal Contraceptives Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Combined Hormonal Contraceptives Market Share by Country (2021-2026) Table 171. Middle East and Africa Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Combined Hormonal Contraceptives Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Combined Hormonal Contraceptives Distributors List Table 176. Combined Hormonal Contraceptives Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Combined Hormonal Contraceptives Image Figure 2. Global Combined Hormonal Contraceptives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Combined Hormonal Contraceptives Market Size (2021-2032) & (US$ Million) Figure 4. Global Combined Hormonal Contraceptives Sales (2021-2032) & (K Units) Figure 5. Above 44 years Image Figure 6. Global Above 44 years Sales YoY Growth (2021-2032) & (K Units) Figure 7. 35-44 years Image Figure 8. Global 35-44 years Sales YoY Growth (2021-2032) & (K Units) Figure 9. 25-34 years Image Figure 10. Global 25-34 years Sales YoY Growth (2021-2032) & (K Units) Figure 11. 15-24 years Image Figure 12. Global 15-24 years Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Combined Hormonal Contraceptives Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Combined Hormonal Contraceptives Market Share by Type 2025 VS 2032 Figure 15. North America Combined Hormonal Contraceptives Sales Market Share in Volume by Type in 2025 Figure 16. North America Combined Hormonal Contraceptives Sales Market Share in Value by Type in 2025 Figure 17. Europe Combined Hormonal Contraceptives Sales Market Share in Volume by Type in 2025 Figure 18. Europe Combined Hormonal Contraceptives Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share in Value by Type in 2025 Figure 21. Latin America Combined Hormonal Contraceptives Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Combined Hormonal Contraceptives Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Combined Hormonal Contraceptives Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Online Pharmacy Image Figure 30. Global Online Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Pharmacy Image Figure 32. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Combined Hormonal Contraceptives Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Combined Hormonal Contraceptives Market Share by Application 2025 VS 2032 Figure 35. North America Combined Hormonal Contraceptives Sales Market Share in Volume by Application in 2025 Figure 36. North America Combined Hormonal Contraceptives Sales Market Share in Value by Application in 2025 Figure 37. Europe Combined Hormonal Contraceptives Sales Market Share in Volume by Application in 2025 Figure 38. Europe Combined Hormonal Contraceptives Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Combined Hormonal Contraceptives Sales Market Share in Value by Application in 2025 Figure 41. Latin America Combined Hormonal Contraceptives Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Combined Hormonal Contraceptives Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Combined Hormonal Contraceptives Sales Market Share in Value by Application in 2025 Figure 45. North America Combined Hormonal Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Combined Hormonal Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Combined Hormonal Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Combined Hormonal Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Combined Hormonal Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Combined Hormonal Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Combined Hormonal Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Combined Hormonal Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Combined Hormonal Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Combined Hormonal Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Combined Hormonal Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Combined Hormonal Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Combined Hormonal Contraceptives Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Combined Hormonal Contraceptives Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Combined Hormonal Contraceptives Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Combined Hormonal Contraceptives Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Combined Hormonal Contraceptives Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Combined Hormonal Contraceptives Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Above 44 years
  • 35-44 years
  • 25-34 years
  • 15-24 years
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Mylan
  • Bayer
  • Ortho-McNeil-Janssen Pharmaceuticals
  • Noven Pharmaceuticals
  • ANI Pharmaceuticals
  • Allergan
  • Agile Therapeutics
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Combined Hormonal Contraceptives Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Combined Hormonal Contraceptives Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Combined Hormonal Contraceptives Market by Type
  6. 1.3.1 Above 44 years
  7. 1.3.2 35-44 years
  8. 1.3.3 25-34 years
  9. 1.3.4 15-24 years
  10. 1.4 Global Combined Hormonal Contraceptives Market Size by Type
  11. 1.4.1 Global Combined Hormonal Contraceptives Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Combined Hormonal Contraceptives Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Combined Hormonal Contraceptives Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Combined Hormonal Contraceptives Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Combined Hormonal Contraceptives Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Combined Hormonal Contraceptives Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Combined Hormonal Contraceptives Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Combined Hormonal Contraceptives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Combined Hormonal Contraceptives Industry Trends
  2. 2.2 Combined Hormonal Contraceptives Industry Drivers
  3. 2.3 Combined Hormonal Contraceptives Industry Opportunities and Challenges
  4. 2.4 Combined Hormonal Contraceptives Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Combined Hormonal Contraceptives Revenue (2021-2026)
  2. 3.2 Global Top Players by Combined Hormonal Contraceptives Sales (2021-2026)
  3. 3.3 Global Top Players by Combined Hormonal Contraceptives Price (2021-2026)
  4. 3.4 Global Combined Hormonal Contraceptives Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Combined Hormonal Contraceptives Major Company Production Sites & Headquarters
  6. 3.6 Global Combined Hormonal Contraceptives Company, Product Type & Application
  7. 3.7 Global Combined Hormonal Contraceptives Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Combined Hormonal Contraceptives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Combined Hormonal Contraceptives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Combined Hormonal Contraceptives Tier 1, Tier 2, and Tier 3
4 Combined Hormonal Contraceptives Regional Status and Outlook
  1. 4.1 Global Combined Hormonal Contraceptives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Combined Hormonal Contraceptives Historic Market Size by Region
  3. 4.2.1 Global Combined Hormonal Contraceptives Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Combined Hormonal Contraceptives Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Combined Hormonal Contraceptives Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Combined Hormonal Contraceptives Forecasted Market Size by Region
  7. 4.3.1 Global Combined Hormonal Contraceptives Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Combined Hormonal Contraceptives Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Combined Hormonal Contraceptives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Combined Hormonal Contraceptives by Application
  1. 5.1 Combined Hormonal Contraceptives Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Combined Hormonal Contraceptives Market Size by Application
  6. 5.2.1 Global Combined Hormonal Contraceptives Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Combined Hormonal Contraceptives Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Combined Hormonal Contraceptives Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Combined Hormonal Contraceptives Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Combined Hormonal Contraceptives Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Combined Hormonal Contraceptives Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Combined Hormonal Contraceptives Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Combined Hormonal Contraceptives Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Combined Hormonal Contraceptives Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Combined Hormonal Contraceptives Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Combined Hormonal Contraceptives Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Ortho-McNeil-Janssen Pharmaceuticals
  26. 6.5.1 Ortho-McNeil-Janssen Pharmaceuticals Company Information
  27. 6.5.2 Ortho-McNeil-Janssen Pharmaceuticals Business Overview
  28. 6.5.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
  30. 6.5.5 Ortho-McNeil-Janssen Pharmaceuticals Recent Developments
  31. 6.6 Noven Pharmaceuticals
  32. 6.6.1 Noven Pharmaceuticals Company Information
  33. 6.6.2 Noven Pharmaceuticals Business Overview
  34. 6.6.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Noven Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
  36. 6.6.5 Noven Pharmaceuticals Recent Developments
  37. 6.7 ANI Pharmaceuticals
  38. 6.7.1 ANI Pharmaceuticals Company Information
  39. 6.7.2 ANI Pharmaceuticals Business Overview
  40. 6.7.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 ANI Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio
  42. 6.7.5 ANI Pharmaceuticals Recent Developments
  43. 6.8 Allergan
  44. 6.8.1 Allergan Company Information
  45. 6.8.2 Allergan Business Overview
  46. 6.8.3 Allergan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Allergan Combined Hormonal Contraceptives Product Portfolio
  48. 6.8.5 Allergan Recent Developments
  49. 6.9 Agile Therapeutics
  50. 6.9.1 Agile Therapeutics Company Information
  51. 6.9.2 Agile Therapeutics Business Overview
  52. 6.9.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Agile Therapeutics Combined Hormonal Contraceptives Product Portfolio
  54. 6.9.5 Agile Therapeutics Recent Developments
  55. 6.10 Actavis
  56. 6.10.1 Actavis Company Information
  57. 6.10.2 Actavis Business Overview
  58. 6.10.3 Actavis Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Actavis Combined Hormonal Contraceptives Product Portfolio
  60. 6.10.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Combined Hormonal Contraceptives Sales by Country
  2. 7.1.1 North America Combined Hormonal Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Combined Hormonal Contraceptives Sales by Country (2021-2026)
  4. 7.1.3 North America Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032)
  5. 7.2 North America Combined Hormonal Contraceptives Market Size by Country
  6. 7.2.1 North America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Combined Hormonal Contraceptives Market Size by Country (2021-2026)
  8. 7.2.3 North America Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Combined Hormonal Contraceptives Sales by Country
  2. 8.1.1 Europe Combined Hormonal Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Combined Hormonal Contraceptives Sales by Country (2021-2026)
  4. 8.1.3 Europe Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Combined Hormonal Contraceptives Market Size by Country
  6. 8.2.1 Europe Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Combined Hormonal Contraceptives Market Size by Country (2021-2026)
  8. 8.2.3 Europe Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Combined Hormonal Contraceptives Sales by Country
  2. 9.1.1 Asia-Pacific Combined Hormonal Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Combined Hormonal Contraceptives Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Combined Hormonal Contraceptives Market Size by Country
  6. 9.2.1 Asia-Pacific Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Combined Hormonal Contraceptives Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Combined Hormonal Contraceptives Sales by Country
  2. 10.1.1 South America Combined Hormonal Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Combined Hormonal Contraceptives Sales by Country (2021-2026)
  4. 10.1.3 South America Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032)
  5. 10.2 South America Combined Hormonal Contraceptives Market Size by Country
  6. 10.2.1 South America Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Combined Hormonal Contraceptives Market Size by Country (2021-2026)
  8. 10.2.3 South America Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Combined Hormonal Contraceptives Sales by Country
  2. 11.1.1 Middle East and Africa Combined Hormonal Contraceptives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Combined Hormonal Contraceptives Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Combined Hormonal Contraceptives Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Combined Hormonal Contraceptives Market Size by Country
  6. 11.2.1 Middle East and Africa Combined Hormonal Contraceptives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Combined Hormonal Contraceptives Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Combined Hormonal Contraceptives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Combined Hormonal Contraceptives Value Chain Analysis
  2. 12.1.1 Combined Hormonal Contraceptives Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Combined Hormonal Contraceptives Production Mode & Process
  7. 12.2 Combined Hormonal Contraceptives Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Combined Hormonal Contraceptives Distributors
  10. 12.2.3 Combined Hormonal Contraceptives Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst